In this study a team of researchers from Life Technologies and St. Jude Children’s Research Hospital have performed RNA-Seq using the SOLiD™3 system on samples from five children with acute lymphoblastic leukemia (ALL) with paired samples taken at the time ...
Read More »An optimized protocol for RNA-Seq on the Ion Proton sequencer
Previous studies compared running cost, time and other performance measures of popular sequencing platforms. However, comprehensive assessment of library construction and analysis protocols for Proton sequencing platform remains unexplored. Unlike Illumina sequencing platforms, Proton reads are heterogeneous in length and ...
Read More »Big Industry News – Thermo to buy Affy – Illumina launches liquid biopsy startup
Reuters – Thermo Fisher to buy Affymetrix for $1.3 billion Thermo Fisher Scientific Inc (TMO.N), the world’s largest maker of scientific instruments, said it agreed to buy Affymetrix Inc (AFFX.O) for $1.3 billion in cash, beefing up its genetic analysis ...
Read More »Transcriptome Profiling Grants Launched to Support New Biomarker Discovery
CARLSBAD, Calif.–(BUSINESS WIRE)–Thermo Fisher Scientific will fast-track 12 translational research teams’ gene-expression profiling through an innovative grant program launched today. Selected applicants will receive free next-generation RNA sequencing services to further their research in the field of cancer genomics. “Transcriptome ...
Read More »Next Generation Sequencing (NGS) Market – Global Forecast to 2020
Next Generation Sequencing (NGS) Market by Platforms (Illumina HiSeq, MiSeq, HiSeqX Ten, NextSeq 500,Thermo Fisher Ion Proton/PGM), Bioinformatics (Exome Sequencing, RNA-Seq, ChIP-Seq), Technology (SBS, SMRT) & by Application (Diagnostics, Personalized Medicine) – Global Forecast to 2020 The next generation sequencing ...
Read More »Study finds RNA-Seq, like microarrays, only accurate for relative expression, not absolute quantitation
The collborators at the SEQC/MAQC-III Consortium present primary results from the Sequencing Quality Control (SEQC) project, coordinated by the US Food and Drug Administration. Examining Illumina HiSeq, Life Technologies SOLiD and Roche 454 platforms at multiple laboratory sites using reference ...
Read More »Life Technologies Releases New Research Tool: Oncomine NGS RNA-Seq Gene Expression Browser
SAN DIEGO–(BUSINESS WIRE)–Knowledge of driver mutations is essential to research and development in the pharmaceutical industry for the identification of novel populations and discovery of new cancer drug targets. Gene over-expression is one of the prevalent cancer driver events, but ...
Read More »Life Technologies
Life Technologies offers two great options for transcriptome analysis: Whole transcriptome sequencing, or RNA-Seq, for both discovery and gene expression analysis. Use the Ion Proton™ System combined with Ambion® RNA purification and Ion Torrent™ library construction kits for identification and ...
Read More »